Four-year visual outcomes after photorefractive keratectomy in pilots with low–moderate myopia
BackgroundThe photorefractive keratectomy (PRK) is approved for Air Force pilots in several nations. The occupational environments of pilots in the Air Force are unique, including extremely high altitude, low oxygen tension, high ultraviolet light exposure and high G-force load. The short-term effic...
Gespeichert in:
Veröffentlicht in: | British journal of ophthalmology 2016-02, Vol.100 (2), p.253-257 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BackgroundThe photorefractive keratectomy (PRK) is approved for Air Force pilots in several nations. The occupational environments of pilots in the Air Force are unique, including extremely high altitude, low oxygen tension, high ultraviolet light exposure and high G-force load. The short-term efficacy and safety of PRK for pilots are documented. However, the study for long-term visual and refractive outcomes of PRK in pilots is limited.ObjectiveTo investigate the long-term visual and refractive outcomes in a 4-year follow-up period after PRK in pilots with low to moderate myopia.MethodsThirty-eight eyes of 20 subjects that underwent PRK and recruited to Air Force pilot were evaluated preoperatively and at 3, 6, 12, 24, and 48 months postoperatively.ResultsThe mean patient age was 21.42±0.75 years. The mean preoperative manifest refraction spherical equivalent (SE) was −1.51±1.15 diopters (D). At 4 years postoperatively, the mean SE was −0.29±0.51, 89.5% of eyes achieved 20/20 or better Snellen uncorrected visual acuity, 71.1% of eyes were within ±0.50 D of emmetropia. The refraction stabilised by 6 months and was maintained up to the 4-year follow-up stage.ConclusionsPRK for pilots with low to moderate myopia is safe and effective in the long term. High-altitude environmental stress exposure has no effect on the refractive stability after PRK.Trial registration numberROKAF-ASMC-2015-IRB-002. |
---|---|
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjophthalmol-2015-306967 |